/
Mutations in MCL-1 PEST Region of Breast Cancer on Binding Affinity to Mutations in MCL-1 PEST Region of Breast Cancer on Binding Affinity to

Mutations in MCL-1 PEST Region of Breast Cancer on Binding Affinity to - PowerPoint Presentation

madeline
madeline . @madeline
Follow
70 views
Uploaded On 2023-11-20

Mutations in MCL-1 PEST Region of Breast Cancer on Binding Affinity to - PPT Presentation

BakBax Deeksha Jain Cancer Apoptosis Regulatory Factors BCL2 Regulators MCL1 Amplifications in cancer Myeloid Cell Leukemia 1 MCL1 Pathway Release of cytochrome c Bax Myeloid Cell Leukemia 1 ID: 1033505

crispr mcl gel electrophoresis mcl crispr electrophoresis gel mutation cell binding affinity design sds histidine immunoprecipitation page insertion poly

Share:

Link:

Embed:

Download Presentation from below link

Download Presentation The PPT/PDF document "Mutations in MCL-1 PEST Region of Breast..." is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.


Presentation Transcript

1. Mutations in MCL-1 PEST Region of Breast Cancer on Binding Affinity to Bak/Bax Deeksha Jain

2. Cancer

3. Apoptosis + Regulatory FactorsBCL-2 Regulators MCL-1 Amplifications in cancer

4. Myeloid Cell Leukemia 1 (MCL-1) PathwayRelease of cytochrome cBax

5. Myeloid Cell Leukemia 1 PEST  Proline (P), glutamic acid (E), serine (S), and threonine (T) rich regions Research indications  Deletions/Mutations within PEST affect apoptosis and localization

6. Question + Experimental Design How is this apoptotic functioning affected? Is it through the Bak/Bax pathway?MCL-1-/-MCL-1-MMCL-1+/+Mutation Creation via CRISPR/Cas9Mutation insertion into cell line via lipofectionPCR/Gel Electrophoresis/SequencingValidationPCR/Gel Electrophoresis/SequencingValidationMCL-1 purification via poly-histidine tags Binding affinity via co-immunoprecipitation assayVisualization via SDS-PAGE

7. Experimental Design MCL-1-/-MCL-1-MMCL-1+/+Mutation Creation via CRISPR/Cas9Mutation insertion into cell line via lipofectionPCR/Gel Electrophoresis/SequencingValidationPCR/Gel Electrophoresis/SequencingValidationMCL-1 purification via poly-histidine tags Binding affinity via co-immunoprecipitation assayVisualization via SDS-PAGE

8. Mutation Introduction via CRISPR/Cas9Clustered regularly interspaced short palindromic repeats (CRISPR) CRISPR associated genes (Cas)  helicase and nuclease gRNA Design Repair template design

9. Mutation Introduction via CRISPR/Cas9Introduction of gRNA/Cas9/repair template plasmid into cells via electroporation

10. Mutation Introduction via CRISPR/Cas9

11. Mutation Introduction via CRISPR/Cas9Validation via PCR, gel electrophoresis, sequencing 5’CGTCCACCCTCACGCCAGACTCCCGGAGGGTCGCGCGGCCGCCGCCCATTGGCGCCGAGGTCCCCGACGTCACCGCGACCCCCGCGAGGCTGCTTTTCTTCGCGCCCACCCGCCGCGCGGCGCCGCTTGAGGAGATGGAAGCCCCGGCCGCTGACGCCATCATGTCGCCCGAAGAGGAGCTGGACGGGTACGAGCCGGAGCCTCTCGGGAAGCGGCCGGCTGTCCTGCCGCTGCTGGAGTTGGTCGGGGAATCTGGTAATAACACCAGTACGGACGGGTCACTACCCTCG3’ PAM Sequence PAM Sequence Mutation (G→A)Proline Glutamic Acid Serine Threonine Repair TemplategRNA Forward primer

12. Experimental Design MCL-1-/-MCL-1-MMCL-1+/+Mutation Creation via CRISPR/Cas9Mutation insertion into cell line via lipofectionPCR/Gel Electrophoresis/SequencingValidationPCR/Gel Electrophoresis/SequencingValidationMCL-1 purification via poly-histidine tags Binding affinity via co-immunoprecipitation assayVisualization via SDS-PAGE

13. Experimental Design MCL-1-/-MCL-1-MMCL-1+/+Mutation Creation via CRISPR/Cas9Mutation insertion into cell line via lipofectionPCR/Gel Electrophoresis/SequencingValidationPCR/Gel Electrophoresis/SequencingValidationMCL-1 purification via poly-histidine tags Binding affinity via co-immunoprecipitation assayVisualization via SDS-PAGE

14. Experimental Design MCL-1-/-MCL-1-MMCL-1+/+Mutation Creation via CRISPR/Cas9Mutation insertion into cell line via lipofectionPCR/Gel Electrophoresis/SequencingValidationPCR/Gel Electrophoresis/SequencingValidationMCL-1 purification via poly-histidine tags Binding affinity via co-immunoprecipitation assayVisualization via SDS-PAGE

15. Experimental Design MCL-1-/-MCL-1-MMCL-1+/+Mutation Creation via CRISPR/Cas9Mutation insertion into cell line via lipofectionPCR/Gel Electrophoresis/SequencingValidationPCR/Gel Electrophoresis/SequencingValidationMCL-1 purification via poly-histidine tags Binding affinity via co-immunoprecipitation assayVisualization via SDS-PAGE

16. Experimental Design MCL-1-/-MCL-1-MMCL-1+/+Mutation Creation via CRISPR/Cas9Mutation insertion into cell line via lipofectionPCR/Gel Electrophoresis/SequencingValidationPCR/Gel Electrophoresis/SequencingValidationMCL-1 purification via poly-histidine tags Binding affinity via co-immunoprecipitation assayVisualization via SDS-PAGE

17. DiscussionAll goes well  binding affinity of MCL-1 for Bak/Bax will be decreased given mutation in PEST sequence  increased apoptosis Other results  binding affinity increased or unaffected by specific mutation Concerns Formation of insertion/deletion during CRISPR/Cas9 in off-target locationsHDR v NHEJCan check off target effects via sequencing/BNFO methods/programs for effects in future studies Hidden epitope ie no Ab recognition or pull through in assayMutation targeting PEST region in specific residue not accounted for Findings will help with MCL-1 specific targeting in drugs for targeted therapies Decrease adverse effects of inhibition

18. Thank you!Questions/comments/concerns?

19. References Active Motif. Nuclear Complex Co-IP Kit. (n.d.). Retrieved April 2017, from https://www.activemotif.com/catalog/25/nuclear-complex-co-ip-kit Addgene. CRISPR/Cas9 Guide. Retrieved April 2017, from https://www.addgene.org/crispr/guide/ BioRad. Chemical- and Viral-Based Transfection Methods. (n.d.). Retrieved April 2017, from http://www.bio-rad.com/en-us/applications-technologies/chemical-viral-based-transfection-methodsDemelash, A., Pfannenstiel, L. W., Tannenbaum, C. S., Li, X., Kalady, M. F., Devecchio, J., & Gastman, B. R. (2015). Structure-Function Analysis of the Mcl-1 Protein Identifies a Novel Senescence-regulating Domain. Journal of Biological Chemistry,290(36), 21962-21975. doi:10.1074/jbc.m115.663898Grabow, S., Delbridge, A., Aubrey, B., Vandenberg, C., & Strasser, A. (2016). Loss of a Single Mcl-1 Allele Inhibits MYC-Driven Lymphomagenesis by Sensitizing Pro-B Cells to Apoptosis. Cell Reports,14(10), 2337-2347. doi:10.1016/j.celrep.2016.02.039Germain, M., & Duronio, V. (2007). The N Terminus of the Anti-apoptotic BCL-2 Homologue MCL-1 Regulates Its Localization and Function. Journal of Biological Chemistry,282(44), 32233-32242. doi:10.1074/jbc.m706408200Mojsa, B., Lassot, I., & Desagher, S. (2014). Mcl-1 Ubiquitination: Unique Regulation of an Essential Survival Protein. Cells,3(2), 418-437. doi:10.3390/cells3020418Sharma, S., Javadekar, S. M., Pandey, M., Srivastava, M., Kumari, R., & Raghavan, S. C. (2015). Homology and enzymatic requirements of microhomology-dependent alternative end joining. Cell Death and Disease,6(3). doi:10.1038/cddis.2015.58Thomas, L. W., Lam, C., & Edwards, S. W. (2010). Mcl-1; the molecular regulation of protein function. FEBS Letters,584(14), 2981-2989. doi:10.1016/j.febslet.2010.05.061

20. Lipofection

21. Poly-Histidine Tag

22. Co-Immunoprecipitation Assay

23. SDS-PAGE